|
Mechanism5-HT1A receptor agonists [+4] |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Neuroventi Co., Ltd.
0 Patents (Medical) associated with Neuroventi Co., Ltd.
100 Deals associated with Neuroventi Co., Ltd.
100 Translational Medicine associated with Neuroventi Co., Ltd.